The page is the record's research on the issuer — no analyst, no rating, no view. # LENZ Therapeutics, Inc. (NASDAQ: LENZ) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is LENZ Therapeutics, Inc., listed on NASDAQ under ticker LENZ, with ISIN US52635N1037. Its LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-DE was found. Its security type is Corporate, its segment is not on the record, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States, Delaware. Its listing status is listed, not halted. ## The disclosure read The record holds 50 filings in the twelve months to 2026-11-08, across 29 filing days. The median gap between filing days is 7.5 days. The latest filing is dated 2026-11-05, three days before the record date, and is a regulatory filing. The exchange median is 6.0 days for cadence, 52 filings and 5.0 days for latency across 4,359 NASDAQ issuers. The sector median is 5.5 days for cadence, 65.5 filings and 4.0 days for latency across 176 issuers in the sector. ## Auditor The auditor of record is Ernst & Young LLP, located in San Diego, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page, so the count is 0. ## Open research No openly published research notes were found, so the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is sealed. The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The earliest sealed date of the market is 2021-01-04, and the live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001815776.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/LENZ (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1815776/000181577626000011/lenz-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/LENZ (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/LENZ · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp